Phosphorex, a drug delivery-focused CDMO and an Ampersand Capital Partners portfolio company, has appointed Jerry Williamson ...

Phosphorex, NOF Corporation, NeoSome Life Sciences, NanoImaging Services (NIS), and Envol Biomedical have joined forces to ...

Bayer and Kumquat Biosciences have entered an exclusive global license and collaboration to develop and commercialize Kumquat ...

Avista will leverage Forge’s FUEL platform to manufacture AAV for AVST-101, Avista’s lead gene therapy to treat patients with X-linked retinoschisis (XLRS).

ElevateBio has received certification from the ICMC program for its viral gene delivery, non-viral gene delivery, and cell therapy manufacturing capabilities at its facility in Waltham, Massachusetts.

Oxford BioDynamics (OBD) has partnered with Google Cloud to expand the capabilities of its 3D genomic biomarker technology.

Bionova Scientific has opened a 10,000-square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, ...

Sartorius supports commercialization and joint development of solutions based on Nanotein’s NanoSpark platform.

GSK plc's experimental antibiotic, gepotidacin, has been granted priority review by the U.S. Food and Drug Administration ...

The U.S. Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of ...

ProBio has launched cGMP Adeno-Associated Virus (AAV) manufacturing services at its 128,000 sq. ft. facility in Hopewell, New ...

CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.